FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

francesco caracciolo

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Living Beings

Hepacivirus

Co-author Network

Publications

TOP 3
Giovanni Carulli; Elena Ciabatti; Eugenio Ciancia; Maria I Ferreri; Sara Galimberti; Paola Lambelet; Alessandra Marini; Virginia Ottaviano; Joseph Bruno; Elisa Cannizzo; francesco caracciolo; S Vignati; Mario Petrini
Discordant lymphoma consisting of splenic mantle cell lymphoma and marginal zone lymphoma involving the bone marrow and peripheral blood: a case report.
Daniele Focosi; Matteo Pelosini; Piero Palla; Sara Galimberti; francesco caracciolo; Edoardo Benedetti; Federico Papineschi; Mario Petrini
Hypercytokinemia-induced metabolic encephalopathy in a multiple myeloma patient on hemodialysis undergoing autologous stem cell transplantation: clinical response after plasma exchange.
Giulia Cervetti; Sara Galimberti; Francesca Andreazzoli; Rita Fazzi; Nadia Cecconi; francesco caracciolo; Mario Petrini
Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of francesco caracciolo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Giovanni Carulli; Elena Ciabatti; Eugenio Ciancia; Maria I Ferreri; Sara Galimberti; Paola Lambelet; Alessandra Marini; Virginia Ottaviano; Joseph Bruno; Elisa Cannizzo; francesco caracciolo; S Vignati; Mario Petrini
Discordant lymphoma consisting of splenic mantle cell lymphoma and marginal zone lymphoma involving the bone marrow and peripheral blood: a case report.
Journal of medical case reports 2011;5():476.
2009: Daniele Focosi; Matteo Pelosini; Piero Palla; Sara Galimberti; francesco caracciolo; Edoardo Benedetti; Federico Papineschi; Mario Petrini
Hypercytokinemia-induced metabolic encephalopathy in a multiple myeloma patient on hemodialysis undergoing autologous stem cell transplantation: clinical response after plasma exchange.
Transplant immunology 2009;21(4):240-3.
2008: Giulia Cervetti; Sara Galimberti; Francesca Andreazzoli; Rita Fazzi; Nadia Cecconi; francesco caracciolo; Mario Petrini
Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up.
British journal of haematology 2008;143(2):296-8.
2008: Edoardo Benedetti; francesco caracciolo; Daniele Focosi; Sara Galimberti; Piero Vincenzo Lippolis; E Neri; Federico Papineschi; Matteo Pelosini; Massimo Seccia; S M Stella; Mario Petrini
Ultrasound findings guided a successful hemicolectomy in a leukemic patient with neutropenic enterocolitis.
Journal of ultrasound 2008;11(3):97-101.
2008: Matteo Pelosini; Daniele Focosi; Fazzi Rita; Sara Galimberti; francesco caracciolo; Edoardo Benedetti; Federico Papineschi; Mario Petrini
Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature.
Annals of hematology 2008;87(5):405-12.
2008: Daniele Focosi; francesco caracciolo; Sara Galimberti; Federico Papineschi; Mario Petrini
False positive PET scanning caused by inactivated influenza virus vaccination during complete remission from anaplastic T-cell lymphoma.
Annals of hematology 2008;87(4):343-4.
2008: Daniele Focosi; francesco caracciolo; Sara Galimberti; Federico Papineschi; Mario Petrini
Long-term propylthiouracil use and acute myeloid leukemia: a case report and review of the literature.
Annals of hematology 2008;87(3):233-5.
2008: Gabriele Buda; Enrico Orciuolo; Sara Galimberti; Edoardo Benedetti; francesco caracciolo; Giulia Cervetti; Giovanni Carulli; Federico Papineschi; Mario Petrini
Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemia.
Leukemia research 2008;32(1):192-4.
2007: Balint Nagy; Sara Galimberti; Edoardo Benedetti; francesco caracciolo; Simone Pacini; Juhani Vilpo; Anna Ferrer; Erkki Elonen; Kaarle Franssila; Sakari Knuutila; Mario Petrini
RAF-1 over-expression does condition survival of patients affected by aggressive mantle cell lymphoma.
Leukemia research 2007;31(11):1595-7.
2007: Gabriele Buda; Sara Galimberti; Enrico Orciuolo; francesco caracciolo; Nadia Cecconi; Mauro Gasparini; Mario Petrini
Stable low IgG levels in relapsed non-Hodgkin's lymphomas.
Annals of hematology 2007;86(11):851-3.
2007: Matteo Pelosini; Sara Galimberti; Edoardo Benedetti; francesco caracciolo; Rita Fazzi; Mario Petrini; Federico Papineschi
Skin and stomach graft versus host disease after syngeneic BMT in CML: a case report.
Leukemia research 2007;31(11):1603-4.
2007: Sara Galimberti; Balint Nagy; Edoardo Benedetti; Simone Pacini; Stefania Brizzi; francesco caracciolo; Federico Papineschi; Elena Ciabatti; Francesca Guerrini; Rita Fazzi; Martina Canestraro; Mario Petrini
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen.
Leukemia & lymphoma 2007;48(8):1502-9.
2007: Sara Galimberti; Giuseppe A Palumbo; francesco caracciolo; Edoardo Benedetti; Matteo Pelosini; Stefania Brizzi; Elena Ciabatti; Rita Fazzi; Caterina Stelitano; G Quintana; E Conte; Daniele Tibullo; Francesco Di Raimondo; Mario Petrini
The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphisms.
Journal of chemotherapy (Florence, Italy) 2007;19(3):315-21.
2007: Gabriele Buda; Sara Galimberti; Roberto Scarpato; francesco caracciolo; Giovanni Carulli; Valentina Maggini; Roberto Barale; Mario Petrini
Atypical APL including multiple translocations and abnormal response to micronuclei induction test.
European journal of clinical investigation 2007;37(2):155-6.
2006: Matteo Pelosini; Edoardo Benedetti; Sara Galimberti; francesco caracciolo; Mario Petrini; Rita Fazzi; Francesca Andreazzoli; Federico Papineschi
Granulocytic sarcoma and subsequent acute leukemia recurrence with different biologic characteristics 5 years after allogeneic bone marrow transplantation for acute myeloid leukemia.
Bone marrow transplantation 2006;37(9):897-8.
2005: Giulia Cervetti; S Mechelli; Rossella Riccioni; Sara Galimberti; francesco caracciolo; Mario Petrini
High efficacy of Rituximab in indolent HCV-related lymphoproliferative disorders associated with systemic autoimmune diseases.
Clinical and experimental rheumatology 2005;23(6):877-80.
2004: Giulia Cervetti; Sara Galimberti; Francesca Andreazzoli; Rita Fazzi; Nadia Cecconi; francesco caracciolo; Mario Petrini
Rituximab as treatment for minimal residual disease in hairy cell leukaemia.
European journal of haematology 2004;73(6):412-7.
2004: Sara Galimberti; Giulia Cervetti; Nadia Cecconi; Rita Fazzi; Simone Pacini; Francesca Guerrini; Chiara Manetti; francesco caracciolo; Mario Petrini
Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H).
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(5):389-93.
2004: Giulia Cervetti; Sara Galimberti; Nadia Cecconi; francesco caracciolo; Mario Petrini
Role of low-dose 2-CdA in refractory or resistant lymphoplasmocytic lymphoma.
Journal of chemotherapy (Florence, Italy) 2004;16(4):388-91.
2004: Federico Papineschi; E Benedetti; Sara Galimberti; francesco caracciolo; Rita Fazzi; Mario Petrini
A myeloablative allograft after rejection of two consecutive nonmyeloablative transplants from two different HLA identical siblings.
Bone marrow transplantation 2004;33(6):659-60.
2003: Rossella Riccioni; francesco caracciolo; Sara Galimberti; Nadia Cecconi; Mario Petrini
Low dose 2-CdA schedule activity in splenic marginal zone lymphomas.
Hematological oncology 2003;21(4):163-8.
2003: Rita Fazzi; francesco caracciolo; Sara Galimberti; Mario Petrini
Early reappearance of primary solid cancer in patients treated with purine analogs.
Journal of chemotherapy (Florence, Italy) 2003;15(4):406-8.
2003: Sara Galimberti; Francesca Guerrini; Fortunato Morabito; Giuseppe A Palumbo; Francesco Di Raimondo; Federico Papineschi; francesco caracciolo; Rita Fazzi; Giulia Cervetti; A Cuzzocrea; Mario Petrini
Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab.
Bone marrow transplantation 2003;32(1):57-63.
2003: Giulia Cervetti; francesco caracciolo; Nadia Cecconi; Antonio Azzarà; Mario Petrini
Efficacy and toxicity of liposomal daunorubicin included in PVABEC regimen for aggressive NHL of the elderly.
Leukemia & lymphoma 2003;44(3):465-9.
2002: Rossella Riccioni; Sara Galimberti; Giulia Cervetti; Rita Fazzi; francesco caracciolo; Mario Petrini
Oral cyclophosphamide therapy for patients with residual or relapsed indolent-type lymphoma after initial treatment for aggressive lymphomas. A sub-group of patients with apparent transformed indolent lymphoma.
Leukemia & lymphoma 2002;43(9):1803-6.
2002: Sara Galimberti; Marasca Roberto; francesco caracciolo; Rita Fazzi; Federico Papineschi; Edoardo Benedetti; Francesca Guerrini; Fortunato Morabito; Esther Oliva; N Di Renzo; Massimo Federico; Mario Petrini; Giuseppe Torelli
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma.
Bone marrow transplantation 2002;29(7):581-7.
1997: francesco caracciolo; E Capochiani; Federico Papineschi; Mario Petrini
A new effective treatment for indolent lymphoma: a pilot study with fludarabine, idarubicin and prednisone combination (FLIDA).
Hematological oncology 1997;15(1):27-31.
1997: Anna Linda Zignego; Clodoveo Ferri; Carlo Giannini; Luca la Civita; G Careccia; Giovanni Longombardo; Giampiero Bellesi; francesco caracciolo; V Thiers; Paolo Gentilini
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role.
Archives of virology 1997;142(3):545-55.
1997: Clodoveo Ferri; F Lo Jacono; Monica Monti; francesco caracciolo; Luca la Civita; L A Barsanti; Giovanni Longombardo; F Lombardini; G Careccia; Anna Linda Zignego
Lymphotropic virus infection of peripheral blood mononuclear cells in B-cell non-Hodgkin's lymphoma.
Acta haematologica 1997;98(2):89-94.
1997: francesco caracciolo; E Capochiani; Federico Papineschi; Mario Petrini
Consolidation therapy with idarubicin, cisplatin and prednisone (CIP) after P-VABEC regimen in the treatment of intermediate and high grade non-Hodgkin's lymphoma of the elderly.
Leukemia & lymphoma 1997;24(3-4):355-61.
1996: clodoveo ferri; Luca la Civita; francesco caracciolo; Giampiero Bellesi; Anna Linda Zignego
Hepatitis C virus and lymphoproliferative disorders.
Blood 1996;88(12):4730-1.
1996: Clodoveo Ferri; Luca la Civita; Monica Monti; Carlo Giannini; R Cecchetti; francesco caracciolo; Giovanni Longombardo; F Lombardini; Anna Linda Zignego
Chronic hepatitis C and B-cell non-Hodgkin's lymphoma.
QJM : monthly journal of the Association of Physicians 1996;89(2):117-22.
1995: Giovanni Carulli; S Minnucci; Antonio Azzarà; C Angiolini; Simone Sbrana; francesco caracciolo; Fabio Ambrogi
Granulocyte colony-stimulating factor (G-CSF) administration increases PMN CD32 (FcRII) expression and FcR-related functions.
Haematologica 1995;80(2):150-4.
1995: D Di Simone; R Testi; francesco caracciolo; E Capochiani; Fabio Ambrogi; B Grassi; Mario Petrini
Glutathione-S-transferase activity and multidrug resistance phenotype in chronic lymphocytic leukemia: do they have any clinical relevance?
Haematologica 1995;80(2):103-7.
1994: clodoveo ferri; francesco caracciolo; Anna Linda Zignego; Luca la Civita; M Monti; Giovanni Longombardo; F Lombardini; F Greco; E Capochiani; ALESSANDRO MAZZONI
Hepatitis C virus infection in patients with non-Hodgkin's lymphoma.
British journal of haematology 1994;88(2):392-4.
1994: clodoveo ferri; Luca la Civita; francesco caracciolo; A L Zignego
Non-Hodgkin's lymphoma: possible role of hepatitis C virus.
JAMA : the journal of the American Medical Association 1994;272(5):355-6.
1994: francesco caracciolo; Mario Petrini; E Capochiani; Federico Papineschi; Giovanni Carulli; B Grassi
Alternating chemotherapy regimen (P-VABEC) for intermediate and high-grade non-Hodgkin's lymphoma of the middle aged and elderly.
Hematological oncology 1994;12(4):185-92.
1994: clodoveo ferri; francesco caracciolo; Luca la Civita; M Monti; Giovanni Longombardo; F Greco; Anna Linda Zignego
Hepatitis C virus infection and B-cell lymphomas.
European journal of cancer (Oxford, England : 1990) 1994;30A(10):1591-2.
1993: Mario Petrini; A Conte; francesco caracciolo; A Sabbatini; B Grassi; G Ronca
Reversing of chlorambucil resistance by ethacrynic acid in a B-CLL patient.
British journal of haematology 1993;85(2):409-10.
1993: francesco caracciolo; Mario Petrini; E Capochiani; Federico Papineschi; B Grassi
Third generation chemotherapy with P-VABEC for aggressive non-Hodgkin's lymphomas of the elderly.
Leukemia & lymphoma 1993;11(1-2):115-8.
1993: Mario Petrini; francesco caracciolo; Giovanni Carulli; A Conte; A Sabbatini; Letizia Mattii; B Grassi
Vitamin D3 administration and multidrug resistance in acute nonlymphoblastic leukemia.
Acta haematologica 1993;89(4):184-8.
1991: Mario Petrini; Giovanni Carulli; Letizia Mattii; A Sabbatini; C Pardi; francesco caracciolo; B Grassi
[The pleiotropic drug resistance phenotype: role of reverting agents "in vitro" and "in vivo"].
Haematologica 1991;76 Suppl 3():173-6.
1991: Mario Petrini; francesco caracciolo; M Corini; P Valentini; A R Sabbatini; B Grassi
Low-dose ARA-C and 1(OH) D3 administration in acute non lymphoid leukemia: pilot study.
Haematologica 1991;76(3):200-3.
1990: Giovanni Carulli; Mario Petrini; A Marini; Francesca Vaglini; francesco caracciolo; B Grassi
P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.
Haematologica 1990;75(6):516-21.
1990: Mario Petrini; M Corini; francesco caracciolo; R Giordani; B Grassi
Automatic differential blood counting in plasma cell leukemia.
Haematologica 1990;75(3):269-71.
1990: G Carulli; M Petrini; francesco caracciolo; A Marini; B Grassi
Nicardipine as a chemosensitizing agent in two P-glycoprotein-positive leukemic patients.
Haematologica 1990;75(3):300-1.
1987: M Mian; Luisa Trombi; S Rosini; Dino Benetti; francesco caracciolo; G Carulli; Antonio Azzarà; Fabio Ambrogi
Experimental studies on diacerhein: effects on the phagocytosis of neutrophil cells from subcutaneous carrageenan-induced exudate.
Drugs under experimental and clinical research 1987;13(11):695-8.
1984: Fabio Ambrogi; Mario Petrini; A Azzara; Giovanni Carulli; francesco caracciolo; B Grassi; A Bertelli
Immunomodulators and enzymes of purine metabolism in human lymphocytes.
International journal of tissue reactions 1984;6(5):379-84.
1984: Mario Petrini; Fabrizio Bruschi; francesco caracciolo; Giovanni Carulli; B Grassi; S Ronca-Testoni; R Testi; Fabio Ambrogi
Intralymphocytic adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNPase) activity in chronic lymphocytic leukemia (CLL): effect of thymostimulin.
Advances in experimental medicine and biology 1984;165 Pt B():327-32.
1983: G Carulli; Antonio Azzarà; francesco caracciolo; M Margelli; Fabio Ambrogi; B Grassi
Lithium and acute lymphocytic leukemia.
Haematologica 1983;68(5):698.
1983: Giovanni Carulli; R Polidori; M Petrini; francesco caracciolo; Federico Papineschi; A Azzará
[Functional changes in polymorphonuclear neutrophils in a neutropenic young Negro].
Sangre 1983;28(2):210-5.
1983: Fabio Ambrogi; Mario Petrini; francesco caracciolo; A Azzara; Giovanni Carulli
Effect of thymostimulin on human lymphocyte adenosine deaminase and purine nucleoside phosphorylase activities: physiological and therapeutic effects.
Advances in experimental medicine and biology 1983;166():101-4.
1982: Fabio Ambrogi; Mario Petrini; Giovanni Carulli; francesco caracciolo; R Testi; N Cappelli; S Ronca-Testoni; R Polidori; B Grassi
Adenosine deaminase activity in human cord blood lymphocyte subpopulations.
Cellular immunology 1982;73(2):404-9.
1982: Mario Petrini; Antonio Azzarà; R Polidori; M L Vatteroni; francesco caracciolo; Giovanni Carulli; Fabio Ambrogi
Serum factors inhibiting some leukocytic functions in Hodgkin's disease.
Clinical immunology and immunopathology 1982;23(1):124-32.
1982: G Spremolla; Federico Papineschi; francesco caracciolo
[Aggressive polychemotherapy in prolymphocytic leukemia].
Sangre 1982;27(6):1082-3.